Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
Alofisel | Medic
ALOFISEL 5 × 10E6 CÉLULAS/ML DISPERSION INYECTABLE, 4 viales de 6 ml.
海外再生医療製品#1 Alofisel | 再生医療.net
Alofisel Darvadstrocel（阿洛昔芬）：用途、副作用、警告 - 知乎
Cos'è il 💊 Farmaco ALOFISEL 🗺️ Foglietto Illustrativo Bugiardino Salute ...
Alofisel ® (Darvadstrocel) | PDF | Inflammation | Cytokine
ALOFISEL ® /DARVASTOCREL | EII La Paz | Enfermedad Inflamatoria Intestinal
EC approves Alofisel for complex perianal fistulae in Crohn’s disease
Takeda triplica la capacidad para producir Alofisel
Takeda Showcases Manufacturing Line for Cell Therapy Alofisel | PHARMA ...
Takeda Pharma Withdraws Alofisel from EU Market - Market Access Today
Takeda withdrawing Alofisel from EU market | The Pharmaletter
Interim data from INSPIRE study of Alofisel shows clinical remission ...
This is a great opportunity to learn about Takeda's Alofisel program ...
Takeda’s Cell Therapy Alofisel Approved in Japan | PHARMA JAPAN
Takeda Receives Approval to Manufacture and Market Alofisel ...
NICE’s Rejection Of Takeda’s Alofisel 'Unsurprising,' Says Analyst
Alofisel (darvadstrocel) for the Treatment of Complex Perianal Fistulas ...
Takeda anuncia la autorización para comercializar Alofisel en Europa
Alofisel (darvadstrocel) Receives Approval to Treat Complex Perianal ...
Takeda’s 1st Cell Therapy Alofisel Misses Goal in Key PIII Study ...
Un cumpleaños feliz para Alofisel - Comunicación Salud
EU approves first allogenic therapy for Crohn’s disease Alofisel
ALOFISEL « New Drug Approvals
Administración de Alofisel (darvadstrocel) - YouTube
ALOFISEL 5 × 10E6 CÉLULAS/ML DISPERSION INYECTABLE
Alofisel wycofany w całej UE. Rozpoczęcie terapii już niemożliwe - Medonet
El Ministerio de Sanidad financiará Alofisel (darvadstrocel), la ...
ALOFISEL Trademark of Tigenix, S.A.U. - Registration Number 4888036 ...
Što je Alofisel i kako se koristi za liječenje analnih fistula kod ...
EMA's CAT Endorses Emerging Gene Therapies, Revokes Alofisel License ...
Withdrawal of Alofisel from the EU market -Baupharma
Alofisel (darvadstrocel), il ritiro dal mercato Ue: beneficio clinico ...
Alofisel by Takeda - YouTube
ALOFISEL®, terapia celular para las fístulas perianales de la ...
Darvadstrocel|Alofisel®|42|2019 | PZ – Pharmazeutische Zeitung
Alofisel(darvadstrocel)治疗复杂克罗恩病肛周瘘临床缓解率65%-上市-医保-临床适应症-香港济民药业
Алофисел (Дарвадстроцел) - Купить в Бишкеке, Кыргызстане и СНГ
Alofisel, a Stem Cell Therapy for Crohn's Disease, Approved in Europe
上海元戊医学技术有限公司
Takeda’s Regenerative Therapy “Alofisel” Gets 5.62 Million Yen NHI ...
¿En qué consiste el tratamiento de terapia avanzada con el medicamento ...
アロフィセルについて│アロフィセル.jp 患者さん・ご家族の方へ│武田薬品工業株式会社
アロフィセル注｜【公式】武田薬品 医療関係者向け情報 Takeda Medical site
Takeda Pharmaceutical Company Limited - News, Articles etc. - European ...
Japanese pharmaceutical firm Takeda’s profits hit by €37m impairment ...
アロフィセル.jp -ヒト体性幹細胞加工製品 アロフィセル注についての情報サイト-│武田薬品工業株式会社
Takeda firma con el Ministerio un acuerdo de riesgo compartido para ...
全球首个间充质干细胞疗法FDA获批上市审批历程揭秘_生物器材网
Takeda triplica su capacidad para producir de terapia celular
Takeda, the largest life sciences employer in Mass., keeps reinventing ...
Takeda granted approval of Adzynma in Japan | The Pharmaletter
TiGenix and Takeda Announce Alofisel® (darvadstrocel) Receives Approval ...
Secteur de la santé au Maroc : ce grand corps malade
Cx-601 « New Drug Approvals
אלופיסל (Alofisel)טיפול לפיסטולות פריאנאליות מורכבות במחלת קרוהן | עזרי ...
全球都上市了哪些间充质干细胞的药物，价格贵吗？ - 知乎
Alofisel® – Stammzelltherapeutikum gegen Perianalfisteln bei Morbus Crohn
ALOFISEL®, terapia celular para fístulas perianales después de la ...
异体干细胞疗法Alofisel获欧盟批准，治疗克罗恩病患者复杂性肛周瘘-上市-医保-临床适应症-香港济民药业
揭开干细胞的价格之谜（附全球已上市间充质干细胞药品价格汇总）医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Takeda fabricará en España el primer fármaco europeo con células madre ...
TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval
Los elementos que respiramos | Dciencia
再生医療等製品とは│アロフィセル.jp 患者さん・ご家族の方へ│武田薬品工業株式会社
细胞治疗临床获批的相关产品及趋势医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
未达主要终点！武田异体干细胞疗法折戟Ⅲ期临床|日本_新浪财经_新浪网
» Se autoriza Alofisel® (darvadstrocel) para tratar fístulas perianales ...
Sanidad financia Alofisel, primera terapia celular alogénica fabricada ...
Takeda takes €37m hit manufacturing row back – The Irish Times
脂肪间充质干细胞药物！武田Alofisel治疗克罗恩病患者复杂性肛周瘘疗效显著：临床缓解率65%! - 专区 - 生物谷
Stem Cell Therapy & Darvadstrocel | Hope for Complex Fistulas
Алофисел Дарвадстроцел- Купить в Алматы, Нур-Султане, Казахстане
Todo lo que debes saber sobre Aloffisel: beneficios, aplicaciones y ...
聊一聊日本批准上市的間充質幹細胞藥物：Alofisel - 每日頭條
Home - Spemital Spa
Alofisel: Behandeling van perianale fistels | Info
Alofisel: EU-weiter Rückruf nach Studienversagen | APOTHEKE ADHOC
Maladie de Crohn : ALOFISEL, médicament de thérapie cellulaire pour les ...
Apoptosis in mesenchymal stromal cells activates an immunosuppressive ...
Nace en Granada Alofisel, un tratamiento “único” contra la enfermedad ...
Stock Info Nets: Takeda Pharmaceutical Company (TAK) – Today’s Real ...
未达主要终点！武田异体干细胞疗法折戟Ⅲ期临床医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
BREAKING: Shock announcement as a Takeda pharma plant to close in ...
Takeda’s Japan Earnings Bottomed Out, Now on Pace to Growth from FY2025 ...
